Senate panel advances legislation capping private insurance insulin at $35
Summary
A Senate committee approved a bill to limit the cost of insulin to $35 for people with private health insurance. The vote was bipartisan, with support from both Democrats and some Republicans, but it is not yet clear if the full Senate will pass the measure.Key Facts
- The bill sets a maximum price of $35 for insulin for privately insured patients.
- The Senate Health, Education, Labor and Pensions Committee voted 17-5 in favor.
- Six Republicans supported the bill alongside all Democrats on the committee.
- The goal is to make insulin more affordable for people who rely on it to manage diabetes.
- The bill still needs approval from the full Senate before it can become law.
- Insulin costs have been a concern due to their high prices for many Americans.
- The legislation represents a bipartisan effort to address healthcare costs.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
